Related Experiment Video
Updated: Aug 15, 2026
08:19
Solid Lipid Nanoparticles (SLNs) for Intracellular Targeting Applications
Published on: November 17, 2015
Liposomal Nanotechnology for Cancer Theranostics
1School of Municipal and Environmental Engineering, Harbin Institute of Technology, Harbin 150001, China.
Current Medicinal Chemistry
|March 8, 2017
Summary
Liposomes, versatile nanocarriers, are advancing cancer theranostics. These biomimetic nanoparticles enable targeted drug delivery and multimodal imaging for personalized cancer treatment monitoring.
Area of Science:
- Nanomedicine
- Biomaterials Science
- Oncology
Background:
- Liposomes are biomimetic nanoparticles with a lipid bilayer and aqueous core.
- They serve as nanocarriers for both diagnostic and therapeutic agents.
- Their surface can be modified for targeted delivery.
Purpose of the Study:
- To review advances in cancer theranostic liposomes.
- To highlight their potential in personalized cancer therapy.
- To stimulate further research in nanomedicine.
Main Methods:
- Review of current literature on liposome applications in cancer theranostics.
- Discussion of passive (EPR effect) and active targeting strategies.
- Exploration of multimodal imaging for monitoring drug delivery and efficacy.
Main Results:
- Liposomes can encapsulate hydrophilic and hydrophobic drugs.
- Targeting molecules enhance liposome accumulation in cancerous tissues.
- Multimodal imaging functionalization allows in vivo monitoring of cancer targeting and pharmacokinetics.
Conclusions:
- Liposomes offer a promising platform for cancer theranostics.
- Targeted delivery and imaging capabilities enhance therapeutic outcomes.
- Further research is crucial for clinical translation of theranostic liposomes.
